Cargando…

Identification of a Prognostic Risk Signature of Kidney Renal Clear Cell Carcinoma Based on Regulating the Immune Response Pathway Exploration

PURPOSE: To construct a survival model for predicting the prognosis of patients with kidney renal clear cell carcinoma (KIRC) based on gene expression related to immune response regulation. MATERIALS AND METHODS: KIRC mRNA sequencing data and patient clinical data were downloaded from the TCGA datab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Guangzhen, Xu, Yingkun, Han, Chenglin, Wang, Zilong, Li, Jiayi, Wang, Qifei, Che, Xiangyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787716/ https://www.ncbi.nlm.nih.gov/pubmed/33456463 http://dx.doi.org/10.1155/2020/6657013

Ejemplares similares

A New Survival Model Based on ADAMTSs for Prognostic Prediction in Clear Cell Renal Cell Carcinoma
por: Wu, Guangzhen, et al.
Publicado: (2021)

Genomic and Transcriptome Analysis to Identify the Role of the mTOR Pathway in Kidney Renal Clear Cell Carcinoma and Its Potential Therapeutic Significance
por: Che, Xiangyu, et al.
Publicado: (2021)

Analysis of genomes and transcriptomes of clear cell renal cell carcinomas identifies mutations and gene expression changes in the TGF-beta pathway
por: Che, Xiangyu, et al.
Publicado: (2022)

Using Genomic and Transcriptome Analyses to Identify the Role of the Oxidative Stress Pathway in Renal Clear Cell Carcinoma and Its Potential Therapeutic Significance
por: Che, Xiangyu, et al.
Publicado: (2021)

Angiogenesis Pathway in Kidney Renal Clear Cell Carcinoma and Its Prognostic Value for Cancer Risk Prediction
por: Che, Xiangyu, et al.
Publicado: (2021)

Potential Application of Pyroptosis in Kidney Renal Clear Cell Carcinoma Immunotherapy and Targeted Therapy
por: Qi, Xiaochen, et al.
Publicado: (2022)

A New Prognostic Risk Model Based on PPAR Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma
por: Xu, Yingkun, et al.
Publicado: (2020)

Identification of a New Prognostic Risk Signature of Clear Cell Renal Cell Carcinoma Based on N(6)-Methyladenosine RNA Methylation Regulators
por: Zhang, Yan, et al.
Publicado: (2021)

A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma
por: Wu, Guangzhen, et al.
Publicado: (2020)

Development of a Novel Sphingolipid Signaling Pathway-Related Risk Assessment Model to Predict Prognosis in Kidney Renal Clear Cell Carcinoma
por: Sun, Yonghao, et al.
Publicado: (2022)

A new prognostic risk model based on autophagy-related genes in kidney renal clear cell carcinoma
por: Wu, Guangzhen, et al.
Publicado: (2021)

The mechanism of liver X receptor regulates the balance of glycoFAsynthesis and cholesterol synthesis in clear cell renal cell carcinoma
por: Wang, Qifei, et al.
Publicado: (2023)

Study on HOXBs of Clear Cell Renal Cell Carcinoma and Detection of New Molecular Target
por: Wu, Guangzhen, et al.
Publicado: (2021)

A New Survival Model Based on Cholesterol Biosynthesis-Related Genes for Prognostic Prediction in Clear Cell Renal Cell Carcinoma
por: Qi, Xiaochen, et al.
Publicado: (2021)

The Uniqueness of Clear Cell Renal Cell Carcinoma: Summary of the Process and Abnormality of Glucose Metabolism and Lipid Metabolism in ccRCC
por: Qi, Xiaochen, et al.
Publicado: (2021)

The Role of ERBB Signaling Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma and Establishing a Prognostic Risk Assessment Model for Patients
por: Wang, Zicheng, et al.
Publicado: (2022)

Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis
por: Zhang, Peizhi, et al.
Publicado: (2023)

Tripartite-motif family genes associated with cancer stem cells affect tumor progression and can assist in the clinical prognosis of kidney renal clear cell carcinoma
por: Wu, Guangzhen, et al.
Publicado: (2020)

Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related Genes
por: Xu, Yingkun, et al.
Publicado: (2020)

Glycolysis-Related Genes Serve as Potential Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma
por: Zhang, Yan, et al.
Publicado: (2021)

The role and therapeutic significance of the anoikis pathway in renal clear cell carcinoma
por: Wang, Jin, et al.
Publicado: (2022)

Review and prospect of immune checkpoint blockade therapy represented by PD-1/PD-L1 in the treatment of clear cell renal cell carcinoma
por: GE, WENFEI, et al.
Publicado: (2023)

Identification of PLAUR-related ceRNA and immune prognostic signature for kidney renal clear cell carcinoma
por: Wang, Yu, et al.
Publicado: (2022)

Identification of immunization-related new prognostic biomarkers for papillary renal cell carcinoma by integrated bioinformatics analysis
por: Wu, Ping, et al.
Publicado: (2021)

Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma
por: Hua, Shan, et al.
Publicado: (2022)

Identification of Hypoxia–Immune-Related Gene Signatures and Construction of a Prognostic Model in Kidney Renal Clear Cell Carcinoma
por: Bai, Shuheng, et al.
Publicado: (2022)

Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma
por: Meng, Tong, et al.
Publicado: (2019)

Identification and Validation of a Necroptosis-Related Prognostic Signature for Kidney Renal Clear Cell Carcinoma
por: Cai, Manbo, et al.
Publicado: (2023)

Comparison of the Fatty Acid Metabolism Pathway in Pan-Renal Cell Carcinoma: Evidence from Bioinformatics
por: Wu, Ping, et al.
Publicado: (2021)

Identification of a Prognostic Model Based on Immune Cell Signatures in Clear Cell Renal Cell Carcinoma
por: Shi, Xuezhong, et al.
Publicado: (2022)

Development of an Individualized Immune Prognostic Signature for Clear Cell Renal Cell Carcinoma through the Identification of Differential Immune Genes
por: Wang, Jianfeng, et al.
Publicado: (2021)

A novel prognostic signature of chemokines for survival and immune infiltration in kidney renal clear cell carcinoma
por: Weng, Jianming, et al.
Publicado: (2023)

Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?
por: Wu, Guangzhen, et al.
Publicado: (2019)

Ferroptosis-associated lncRNA prognostic signature predicts prognosis and immune response in clear cell renal cell carcinoma
por: Lai, Jiayi, et al.
Publicado: (2023)

Identification and Verification of Tumor Immune Microenvironment-Related Prognostic Genes in Kidney Renal Clear Cell Carcinoma
por: Kong, Gangcheng, et al.
Publicado: (2022)

Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma
por: Zhong, Ming, et al.
Publicado: (2022)

Potential value of mitochondrial regulatory pathways in the clinical application of clear cell renal cell carcinoma: a machine learning-based study
por: Qi, Xiaochen, et al.
Publicado: (2023)

TYROBP is a potential prognostic biomarker of clear cell renal cell carcinoma
por: Wu, Ping, et al.
Publicado: (2020)

Identification of an Autophagy-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma
por: Chen, Mei, et al.
Publicado: (2020)

Identification of small molecule drugs and development of a novel autophagy‐related prognostic signature for kidney renal clear cell carcinoma
por: Xing, Qianwei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jnfj6ib36csv10osnc6qt51lv1